1. Home
  2. SVRA vs AOSL Comparison

SVRA vs AOSL Comparison

Compare SVRA & AOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • AOSL
  • Stock Information
  • Founded
  • SVRA 2007
  • AOSL 2000
  • Country
  • SVRA United States
  • AOSL United States
  • Employees
  • SVRA N/A
  • AOSL N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • AOSL Semiconductors
  • Sector
  • SVRA Health Care
  • AOSL Technology
  • Exchange
  • SVRA Nasdaq
  • AOSL Nasdaq
  • Market Cap
  • SVRA 528.3M
  • AOSL 616.9M
  • IPO Year
  • SVRA N/A
  • AOSL 2010
  • Fundamental
  • Price
  • SVRA $2.06
  • AOSL $24.12
  • Analyst Decision
  • SVRA Buy
  • AOSL Buy
  • Analyst Count
  • SVRA 7
  • AOSL 3
  • Target Price
  • SVRA $7.57
  • AOSL $32.33
  • AVG Volume (30 Days)
  • SVRA 2.5M
  • AOSL 397.1K
  • Earning Date
  • SVRA 08-11-2025
  • AOSL 08-06-2025
  • Dividend Yield
  • SVRA N/A
  • AOSL N/A
  • EPS Growth
  • SVRA N/A
  • AOSL N/A
  • EPS
  • SVRA N/A
  • AOSL N/A
  • Revenue
  • SVRA N/A
  • AOSL $680,974,000.00
  • Revenue This Year
  • SVRA N/A
  • AOSL $7.05
  • Revenue Next Year
  • SVRA N/A
  • AOSL $2.54
  • P/E Ratio
  • SVRA N/A
  • AOSL N/A
  • Revenue Growth
  • SVRA N/A
  • AOSL 3.57
  • 52 Week Low
  • SVRA $1.89
  • AOSL $15.90
  • 52 Week High
  • SVRA $5.11
  • AOSL $53.29
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 34.43
  • AOSL 56.36
  • Support Level
  • SVRA $2.13
  • AOSL $22.79
  • Resistance Level
  • SVRA $2.49
  • AOSL $24.87
  • Average True Range (ATR)
  • SVRA 0.15
  • AOSL 1.20
  • MACD
  • SVRA -0.01
  • AOSL 0.05
  • Stochastic Oscillator
  • SVRA 8.41
  • AOSL 70.18

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

Share on Social Networks: